Tasly Pharmaceutical Group Co., Ltd (SHA: 600535)

China flag China · Delayed Price · Currency is CNY
15.72
+0.06 (0.38%)
Nov 12, 2024, 3:00 PM CST
5.43%
Market Cap 23.48B
Revenue (ttm) 8.57B
Net Income (ttm) 881.05M
Shares Out 1.49B
EPS (ttm) 0.59
PE Ratio 26.76
Forward PE 15.72
Dividend 0.52 (3.32%)
Ex-Dividend Date Oct 10, 2024
Volume 29,020,178
Open 15.61
Previous Close 15.66
Day's Range 15.61 - 16.09
52-Week Range 12.24 - 18.00
Beta 0.41
Analysts n/a
Price Target n/a
Earnings Date Oct 28, 2024

About Tasly Pharmaceutical Group

Tasly Pharmaceutical Group Co., Ltd engages in the pharmaceutical business in China and internationally. It provides cardiovascular, anti-tumor, cold and fever, liver disease treatment, and other disease solutions. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is based in Tianjin, China. [Read more]

Sector Healthcare
Founded 1994
Employees 9,223
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600535
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.